United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series 2020-2022
Epi surveillance:
Health facility - Subnationally representative
Blood tests
Dataset Records for Blood tests
Displaying 151 - 200 of 1718
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?
GHDx Entry last modified on: Mar 14, 2022
Belgium Prevalence of anti-SARS-CoV-2 antibodies (IgG) among blood donors 2020-2021
Belgium COVID-19 Studies, Seroprevalence in Blood Donors
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study
GHDx Entry last modified on: Mar 14, 2022
India COVID-19 Official Government of India updates - Twitter 2020-2022
GHDx Entry last modified on: Aug 28, 2023
France COVID-19 Epidemic Monitoring Dashboard 2020-2022
Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2)
Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)
Survey:
Epi surveillance
Switzerland COVID-19 PCR Antigen Tests by Region 2020
Daily record timelines by geoRegion and test type (pcr/antigen) for testsonen
Epi surveillance:
Subnationally representative
Cape Verde STEPS Noncommunicable Disease Risk Factors Survey 2020
Segundo Inquérito Nacional sobre os Fatores de Risco das Doenças Não Transmissíveis (IDNT II)
Survey:
Cross-sectional - Individual - Interview - Nationally representative
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
GHDx Entry last modified on: Feb 10, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
[Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation]
ОСОБЕННОСТИ ФОРМИРОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ НАСЕЛЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ К НУКЛЕОКАПСИДУ SARS-CoV-2 В ПЕРВУЮ ВОЛНУ ЭПИДЕМИИ COVID-19
Sero-prevalence Findings from Metropoles in Pakistan: Implications for Assessing COVID-19 Prevalence and Case-fatality within a Dense, Urban Working Population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?
GHDx Entry last modified on: Jan 31, 2024
Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde. Preprint
GHDx Entry last modified on: Mar 14, 2022
[Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras with no report of active cases, COVID-19, June 16-23, 2020]
Vigilancia seroepidemiológica de la circulación del SARS-CoV-2 en 41 municipios de Honduras sin reporte de casos activos, COVID-19, del 16- 23 junio 2020
Type 2 diabetes prevalence, awareness, and risk factors in rural Mali: a cross-sectional study
GHDx Entry last modified on: Dec 12, 2023
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region. Preprint.
GHDx Entry last modified on: Mar 14, 2022
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study. Preprint
GHDx Entry last modified on: May 12, 2022
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Is Karachi Knocking at Herd Immunity? A Possible Reason for Decline in SARS-CoV-2 Infections. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Scientific literature:
Cross-sectional
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
GHDx Entry last modified on: Jan 31, 2024
Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children. Preprint
GHDx Entry last modified on: Mar 14, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint
GHDx Entry last modified on: Mar 14, 2022
A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jan 31, 2024
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
GHDx Entry last modified on: Jan 31, 2024
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
GHDx Entry last modified on: May 12, 2022
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
Subscribe